Amwill Healthcare IPO Allotment Status: Check Latest GMP, Steps To Verify Status

Amwill Health Care Limited specializes in derma-cosmetic solutions, working closely with contract manufacturers, distributors, and third-party development agencies. The IPO bidding window opened on February 5, 2025 and was closed on February 7, 2025.

Amwill Healthcare IPO Allotment Status Online

 Check Amwill Healthcare IPO Allotment Status on BSE 

1. Open the Application Status page of BSE here
2. Choose 'equity' as the issue type. 
3. Select 'Amwill Healthcare' from the list of companies. 
4. Enter your IPO application number or PAN details. 
5. Verify the captcha by clicking on the 'I am not a Robot' box. 
6. Click on the submit button to check the details of the share allotment. 

Check Amwell Healthcare IPO Allotment Status on BigShare Services

1. Visit the official website of the registrar Bigshare Services Pvt Ltd.here
2. Click any of the server links. 
3. Select 'Amwill Healthcare' from the dropdown menu. 
4. Enter any of these details (Application Number, Beneficiary ID or PAN). 
5. Clear Captcha. 
6. Click Search to get allotment details.

IPO Details

Amwill Healthcare has launched its IPO with a total issue size of ₹59.98 crores. The offering comprises a fresh issue of 44.04 lakh shares, raising ₹48.88 crores, along with an offer for sale of 10.00 lakh shares, amounting to ₹11.10 crores. The price band for the IPO is fixed between ₹105 and ₹111 per share. Investors can participate with a minimum lot size of 1,200 shares, requiring a retail investment of at least ₹1,33,200. High Net-worth Individuals (HNIs) must apply for a minimum of 2 lots (2,400 shares), amounting to ₹2,66,400.

Use of Proceeds

The company plans to allocate the Net Proceeds towards meeting its working capital requirements, enhancing marketing and brand-building initiatives, and addressing general corporate purposes.

Amwill Healthcare IPO Overall Subscription Status 

(February 7, 2025, End of Day)

The Amwill Healthcare IPO was subscribed  5.73 times overall. The retail category saw a subscription of  4.77 times, while Qualified Institutional Buyers (QIBs) was subscribed  7.8 times. The Non-Institutional Investors (NII) category was subscribed  4.77 times. 

GMP (Grey Market Premium) Details

According to NDTV Profit, as of February 10, 2025, the Grey Market Premium (GMP) for Amwill Healthcare SME IPO is ₹0. Based on the upper price band of ₹111.00, the estimated listing price remains at ₹111, reflecting no anticipated gain or loss per share, with a projected percentage change of 0.00%.

Disclaimer: The GMP (Grey Market Premium) price is unauthenticated market-related news and has no discernible basis. The same quoted above is as per news that appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade or deal in the grey market nor do we recommend or endorse trading in the grey market.

Amwill Healthcare  Business Overview

Established in August 2017, Amwill Health Care Limited specializes in derma-cosmetic solutions, working closely with contract manufacturers, distributors, and third-party development agencies. Through these partnerships, the company has enhanced its capabilities in manufacturing, packaging, and distribution.

Amwill Health Care’s product range is categorized into two main segments:

• Generic Dermatological Solutions – Offering widely used skincare and dermatology products.
• Targeted Dermatological Treatments – Developing specialized formulations to address specific skin concerns.

Currently, the company markets its products in Karnataka, Andhra Pradesh, and Telangana. By focusing on these regions first, Amwill aims to establish a strong foothold before expanding into new markets.

Disclaimer: Investing in SME IPOs involves a high degree of risk. Such investments may be suitable only for investors with a high-risk tolerance and the ability to bear potential losses. Perform thorough due diligence and consult a financial advisor before investing. Invest wisely and at your own discretion.